Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Recruiting
700 enrolled
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
Completed
119 enrolled
The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment
Recruiting
170 enrolled
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
Completed
563 enrolled
HPGD-ccRCC
Completed
40 enrolled
HPV & HNSCC
Recruiting
550 enrolled
ENPP1-BC
Completed
12 enrolled
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
Completed
360 enrolled
AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer
Completed
541 enrolled
EPIcol
Unknown
180 enrolled
Hepatobiliary Tumors Tissue Samples Acquisition
Unknown
450 enrolled
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.
Unknown
52 enrolled
Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma
Completed
60 enrolled
Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients
Completed
3,582 enrolled
Assessment of Candidate Protein Expression in Breast Cancer Specimens
Completed
460 enrolled
Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies
Completed
80 enrolled
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
Completed
1,195 enrolled
IMMUNOREACT2
Unknown
544 enrolled
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Completed
175 enrolled
EPNEC
Completed
86 enrolled
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
Completed
397 enrolled
Fibrotic Focus in Breast Cancer
Unknown
250 enrolled
SUCCESS
Unknown
30 enrolled
PACE4 in Thyroid Cancer
Completed
39 enrolled
GLUT1
Completed
36 enrolled
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Completed
56 enrolled
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
Completed
155 enrolled
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
Terminated
126 enrolled
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery
Completed
37 enrolled
Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer
Withdrawn
Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer
Completed
204 enrolled
Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab
Completed
200 enrolled
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
Completed
37 enrolled
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
Completed
2,541 enrolled
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
Completed
307 enrolled
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Completed
559 enrolled
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Completed
363 enrolled
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab
Completed
79 enrolled
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
Completed
69 enrolled
Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Completed
42 enrolled
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
Completed
155 enrolled
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
Completed
689 enrolled
Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer
Completed
30 enrolled
Study of Proteins in Head and Neck Cancer Cells
Completed
Prognostic Value of PD-L1 in NSCLC
Unknown
350 enrolled
S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911
Completed
180 enrolled
Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity
Completed
71 enrolled
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Completed
135 enrolled
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Completed
25 enrolled
Biomarkers in Native American Women With Breast Cancer
Completed
120 enrolled